Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's Disease.

Painchart, Claire

Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's Disease. [electronic resource] - Digestive diseases and sciences 05 2020 - 1445-1452 p. digital

Publication Type: Evaluation Study; Journal Article

1573-2568

10.1007/s10620-019-05865-3 doi


Adult
Biomarkers--blood
Crohn Disease--blood
Female
Humans
Induction Chemotherapy
Male
Middle Aged
Prospective Studies
Reference Values
Treatment Outcome
Ustekinumab--blood